bpc 157 legal status us 2026 fda If BPC-157 worked as well as the internet says it does… …we'd probably have high quality human trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of AICAR FDA Status and Legal
Description
Nasal blend composition from source list: TB-500 0.5mg and BPC-157 0.5mg.

WADA has not specifically listed retatrutide on the prohibited-substances list as of the 2026 list, but its parent class (GLP-1/GIP receptor agonists used for weight management) is subject to ongoing WADA monitoring and reporting

, ,

But there is still little clinical research in dogs, and the use in a veterinary practice is still regarded as an investigational/off-label use